Systematic review of physical and chemical compatibility of commonly used medications administered by continuous infusion in intensive care units

被引:92
作者
Kanji, Salmaan [1 ,2 ,3 ]
Lam, Jason [1 ]
Johanson, Christel [1 ]
Singh, Avinder [1 ]
Goddard, Rob [1 ]
Fairbairn, Jennifer [1 ]
Lloyd, Tammy [1 ]
Monsour, Danny [3 ]
Kakal, Juzer [3 ]
机构
[1] Ottawa Hosp, Dept Pharm, Ottawa, ON, Canada
[2] Ottawa Hosp, Dept Crit Care, Ottawa, ON, Canada
[3] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada
关键词
physical compatibility; chemical compatibility; drug infusions; intensive care unit; Y-SITE INJECTION; PARENTERAL NUTRIENT SOLUTIONS; INTRAVENOUS ADMIXTURE COMPATIBILITY; AMIODARONE HYDROCHLORIDE INJECTION; PROPOFOL INJECTABLE EMULSION; SODIUM-CHLORIDE INJECTION; VISUAL COMPATIBILITY; MORPHINE-SULFATE; MIDAZOLAM HYDROCHLORIDE; ESMOLOL HYDROCHLORIDE;
D O I
10.1097/CCM.0b013e3181e8adcc
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To quantify the physical and chemical stability data published for commonly used continuously infused medications in the intensive care unit and to evaluate the quality of the studies providing these data. Data Sources and Study Selection: We conducted a systematic electronic literature search of MEDLINE, EMBASE, and International Pharmaceutical Abstracts as well as the references of electronic drug compatibility textbooks for all English and French language research publications evaluating the physical compatibility or chemical stability of the 820 possible two-drug combinations of 41 commonly used drugs in an adult intensive care unit. Data Extraction and Synthesis: A total of 93 studies comprised of 86 (92%) studies evaluating physical compatibility and 35 (38%) studies evaluating chemical compatibility of at least one drug combination of interest were included. Physical and/or chemical compatibility data exist for only 441 of the possible 820 two-drug combinations (54%), whereas chemical compatibility data exist for only 75 (9%) of the possible combinations. Of the 441 combinations for which compatibility data are available, 67 (15%) represent incompatible combinations and 39 (9%) had conflicting data in which both compatible and incompatible data were identified. Conclusions: Physical compatibility studies that provide the basis for y-site compatibility are lacking for commonly used medications in intensive care unit patients and may contribute to unsafe medication practices. Furthermore, the heterogeneity in the methodology of these studies likely contributes to the common finding of conflicting data for specific combinations of drugs. Future studies should apply similar methodologic and reporting principles to be able to reproduce and compare outcomes both clinically and in the laboratory. (Crit Care Med 2010; 38:1890-1898)
引用
收藏
页码:1890 / 1898
页数:9
相关论文
共 107 条
[91]   Compatibility of parenteral nutrient solutions with selected drugs during simulated Y-site administration [J].
Trissel, LA ;
Gilbert, DL ;
Martinez, JF ;
Baker, MB ;
Walter, WV ;
Mirtallo, JM .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1997, 54 (11) :1295-1300
[92]   Everything in a compatibility study is important [J].
Trissel, LA .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (24) :2990-2990
[93]   Compatibility of medications with 3-in-1 parenteral nutrition admixtures [J].
Trissel, LA ;
Gilbert, DL ;
Martinez, JF ;
Baker, MB ;
Walter, WV ;
Mirtallo, JM .
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 1999, 23 (02) :67-74
[94]   AVOIDING COMMON FLAWS IN STABILITY AND COMPATIBILITY STUDIES OF INJECTABLE DRUGS [J].
TRISSEL, LA .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1983, 40 (07) :1159-1160
[95]   Drug compatibility differences with propofol injectable emulsion products [J].
Trissel, LA .
CRITICAL CARE MEDICINE, 2001, 29 (02) :466-467
[96]   Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration [J].
Trissel, LA ;
Gilbert, DL ;
Martinez, JF .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1997, 54 (11) :1287-1292
[97]   Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration [J].
Trissel, LA ;
Martinez, JF ;
Gilbert, DL .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1997, 54 (15) :1735-1741
[98]   STABILITY STUDIES - 5 YEARS LATER [J].
TRISSEL, LA ;
FLORA, KP .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1988, 45 (07) :1569-1571
[99]   Compatibility of neonatal parenteral nutrient solutions with selected intravenous drugs [J].
Veltri, M ;
Lee, CKK .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (21) :2611-2613
[100]   Physical compatibility of milrinone lactate injection with intravenous drugs commonly used in the pediatric intensive care unit [J].
Veltri, MA ;
Conner, KG .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (05) :452-454